European Archives - Page 563 of 1124 - European Medical Journal

EMJ Nephrology 9 [Supplement 3] 2021 Feature Image

Unmet Medical Needs in Chronic-Kidney-Disease-Associated Pruritus

CKD-aP necessitates a differential diagnosis to ascertain that the itching a patient is experiencing is related to…

EMJ

EMJ Nephrology 9 [Supplement 3] 2021

PRURITUS is a common challenging symptom seen in chronic kidney disease (CKD). Approximately 40% of patients with end-stage renal…

Roundtable: A new dawn for data

How is the data revolution going to impact the marketing and medical functions?

Neuroprosthesis Restores Speech in Paralysed Man

Breakthrough “speech neuroprosthesis” has allowed a man with severe paralysis to communicate using sentences. Find out more

Can Cognitive Decline Predict Faster Bone Loss?

Novel research has demonstrated that cognitive decline measured over 5 years increases future fracture risk in women. Find out more

Rare Genetic Variant Leads to Six-Fold Increase in Diabetes Risk

New evidence has emerged linking the presence of a rare genetic variant to an increased risk of developing Type 2 diabetes mellitus.

Could Antidepressants Improve Outcomes for Sufferers of Diabetes and Depression?

Could antidepressants improve outcomes for sufferers of diabetes and depression? Read the article and find out more

The rare disease disparity

Some thoughts about how the Rare Disease Act impacted pharma and if it needs further updating after almost 20 years.

SCIENTIFIC UPDATE FROM THE GLOBAL MEETING OF EXPERTS IN DERMATOLOGY (GMED 2021)

Scientific Update from the Global Meeting of Experts in Dermatology (GMED 2021)

During this Global Meeting of Experts in Dermatology symposium, on May 29th 2021, 8 experts of dermatology from Ireland, Italy, and…

Talking to Dirk Kosche

Dirk Kosche, President, Established Markets, Astellas Pharma Europe, discusses turning innovation into value for patients.